NCT07446556

Brief Summary

This randomized controlled trial compares a 6-month physiotherapy exercise program versus no structured exercise intervention in women with pudendal neuralgia. Outcomes include pelvic floor muscle stiffness measured by shear-wave elastography (SWE), pelvic floor symptom burden (PFIQ-7), sexual distress (FSDS-R), and pain/discomfort scores (VAS).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
83

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
Mar 2026Sep 2026

First Submitted

Initial submission to the registry

February 26, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

March 2, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 3, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 2, 2026

Expected
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 5, 2026

Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

6 months

First QC Date

February 26, 2026

Last Update Submit

March 12, 2026

Conditions

Keywords

Pudendal neuralgia Chronic pelvic pain Pelvic floor physiotherapy Shear-wave elastography Pelvic floor muscle stiffness

Outcome Measures

Primary Outcomes (1)

  • Pelvic floor muscle stiffness by shear-wave elastography (SWE)

    Pelvic floor muscle stiffness (kPa) measured by shear-wave elastography in superficial pelvic floor muscles (bulbospongiosus, ischiocavernosus, and superficial transverse perineal muscles). Measurements were obtained using a 2 mm circular ROI with real-time quality control (RLB \> 90%, M-STB 4-5 stars). Shell analysis was used to identify sites of minimum and maximum stiffness within each muscle.

    Baseline and 6 months (post-intervention)

Secondary Outcomes (3)

  • Pelvic Floor Impact Questionnaire-Short Form 7 (PFIQ-7)

    Baseline and 6 months (post-intervention)

  • Female Sexual Distress Scale-Revised (FSDS-R)

    Baseline and 6 months (post-intervention)

  • Pain/discomfort intensity by visual analog scale (VAS)

    Baseline and 6 months (post-intervention)

Study Arms (2)

Pelvic Floor Relaxation Protocol

EXPERIMENTAL

Participants received a 6-month physiotherapy intervention consisting of 6 individual sessions with a physiotherapist and daily home exercise (30 minutes/day).

Behavioral: Pelvic Floor Relaxation Protocol

Control

NO INTERVENTION

Participants did not receive the structured physiotherapy exercise program.

Interventions

A structured 6-month physiotherapy program was implemented, focusing on pelvic floor muscle relaxation, postural correction, and functional movement patterns.The program included 6 individual sessions with a physiotherapist and mandatory daily home exercise (30 minutes/day). Adherence was recorded in participant diaries.

Pelvic Floor Relaxation Protocol

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsYes (if PRS asks whether eligibility is based on sex/gender)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female participants aged 18 years or older
  • Confirmed diagnosis of pudendal neuralgia based on all five Nantes diagnostic criteria
  • Duration of symptoms at least 3 months
  • Written informed consent provided

You may not qualify if:

  • History of psychiatric, neurological (except pudendal neuralgia), severe internal medical, orthopedic, or oncological disease
  • Botulinum toxin therapy within the previous 12 months
  • Pelvic surgery within the previous 12 months
  • Incomplete or incorrectly completed questionnaires
  • Refusal to participate or withdrawal of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Comenius University Bratislava, Jessenius Faculty of Medicine in Martin, Slovakia

Martin, Slovakia, Slovakia

Location

Study Officials

  • Magdalena Hagovska, prof.PhDr.PhD.

    Pavol Jozef Safarik University, Medical Faculty, Kosice Slovakia

    PRINCIPAL INVESTIGATOR
  • Jan Svihra, prof.MUDr.PhD.

    Comenius University Bratislava, Jessenius Faculty of Medicine in Martin, Slovakia

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2026

First Posted

March 3, 2026

Study Start

March 2, 2026

Primary Completion (Estimated)

September 2, 2026

Study Completion (Estimated)

September 5, 2026

Last Updated

March 16, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations